Igc Pharma, INC

Claim this page

Their homepage, crawled JUL 29, 2026

At a glance

EmployeesNot reported

In business sinceNot reported

Industry

Pharmaceutical Preparation Manufacturing

HeadquartersPotomac, MD

SAM.gov UEICP69HP5X14G1

CAGE code8P6R3

Incorporated inMD

Brands

CALMA Clinical TrialIGC-AD1 MedicationMINT-AD AI Platform

This company sells these brands.

IGC Pharma is a clinical-stage biotechnology company advancing Alzheimer's research. The company develops IGC-AD1, a partial CB1 receptor agonist with anti-inflammatory action designed to treat agitation in patients with dementia due to Alzheimer's disease, which is currently in Phase 2 clinical trials under the CALMA study. The company also uses artificial intelligence to analyze multimodal data for early Alzheimer's prediction.

Supplier designations

Self-certified by the company in its SAM.gov registration

Facility	City	State	Employees	Status
Igc Pharma, INC	Potomac	MD	—	◐ LIKELY ACTIVE

Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.